Clinical Trial

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

Name: First-Time-in-Human Study of GSK5471713 in Adults With mCRPC — clinical trial record (NCT07332455)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This first-time-in-human study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, preliminary clinical activity, and establish the benefit/risk of GSK5471713 given as a monotherapy in mCRPC.

Protocol Amendment History 1 change

notable Trial sites expanded: 3 -> 6 locations 2026-04-23

Trial Details

NCT Number	NCT07332455
Lead Sponsor	GlaxoSmithKline
Conditions	Neoplasms, Prostate
Enrollment	54 participants
Start Date	2026-02-10
Primary Completion	2028-03-24 (estimated)
Study Completion	2030-03-26 (estimated)
Updated on ClinicalTrials.gov	2026-07-24